CD4 and hepatocellular carcinoma: Our data, in conjunction with our prior work on the decreased frequency of regulatory T cells (Tregs) and altered CD4/CD8 ratios,21 underscore the compromised immunological landscape in HCC, necessitating immunomodulatory strategies during treatment.